Biotech

All Articles

A better examine Strong Biotech's Ferocious 15

.In this full week's incident of "The Best Pipe," we're diving right into Strong Biotech's yearly Fi...

Lilly faces stage 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party commemorating the commendation of Alzhe...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings as wel...

Lykos will certainly talk to FDA to reassess its own selection observing rejection of MDMA treatment for trauma

.Adhering to an inadequate revealing for Lykos Therapies' MDMA prospect for post-traumatic stress di...

AN 2 halves headcount, stops phase 3 trial after records let down

.AN2 Therapies is actually reconsidering its own company in reaction to poor midphase information, s...

Merck pays out $700M for bispecific, spying autoimmune position and also possibility to test Amgen in cancer cells

.Merck &amp Co. is paying out $700 thousand beforehand to challenge Amgen in a blood cancer market. ...

Gilead pays out J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA selection for its own liver illness medicine sela...

' All palms on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can easily observe the providers establishing tents at basecamp behind Eli Lilly in...

Entero laying off team, abandoning office and stopping briefly R&ampD

.Mattress Liquidators has actually turned Entero Therapies white colored as a piece. The collector o...

Exelixis loses ADC after choosing it's no match for Tivdak

.Exelixis is actually surrendering on its cells aspect (TF)- targeting antibody-drug conjugate after...